1Ganem D,Prince AM. Hepatitis B virus infection-natural history and clinical conesquences[J].New England Journal of Medicine,2004,(11):1118-1129.
2World Health Organization. Hepatitis B[OL].http://www.who.int/mediacentre/factsheets/fs204/en/,2010.
3Bosch FX,Ribes J,Cleries R. Epidemiology of hepatocellular carcinoma[J].Clinics in Liver Disease,2005,(02):191-211.doi:10.1016/j.cld.2004.12.009.
4Chen CJ,Yang HI,Su J. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level[J].Journal of the American Medical Association,2006,(05):65-73.
8Marcellin P,Chang TT,Lim SG. Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B[J].Hepatology,2008,(03):750-758.doi:10.1002/hep.22414.
9Gish RG,Lok AS,Chang TT. Entecavir therapy for up to 96 weeks in patients with HBeAg positive chronic hepatitis B[J].Gastroenterology,2007,(03):1437-1444.
10Lai CL,Lim SG,Brown NA. A dose-finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infection[J].Hepatology,2004,(03):719-726.
2Susanne J Szabo,Sean T Kim,Gina L Costa,Xiankui Zhang,C.Garrison Fathman,Laurie H Glimcher.A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment[J].Cell.2000(6)
3Alejandro R. Jadad,R.Andrew Moore,Dawn Carroll,Crispin Jenkinson,D.John M. Reynolds,David J. Gavaghan,Henry J. McQuay.Assessing the quality of reports of randomized clinical trials: Is blinding necessary?[J].Controlled Clinical Trials.1996(1)
4Fumitaka Suzuki,Norio Akuta,Yoshiyuki Suzuki,Hiromi Yatsuji,Hitomi Sezaki,Yasuji Arase,Yusuke Kawamura,Tetsuya Hosaka,Masahiro Kobayashi,Kenji Ikeda,Mariko Kobayashi,Sachiyo Watahiki,Hiromitsu Kumada.Selection of a virus strain resistant to entecavir in a nucleoside-naive patient with hepatitis B of genotype H[J].Journal of Clinical Virology.2007(2)
5Fabien Zoulim,Stephen Locarnini.Hepatitis B Virus Resistance to Nucleos(t)ide Analogues[J].Gastroenterology.2009(5)
6Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure[J]. Journal of Hepatology . 2008 (5)
7Ganem D,Prince AM.Hepatitis B virus infection-natural history and clinical consequences. New England Journal of Homeopathy . 2004
8Liaw YF,Sung JJ,Chow WC,et al.Lamivudine for patients with chronic hepatitis B and advanced liver disease. The New England Journal of Medicine . 2004
9Lieven J. Stuyver,Stephen A. Locarnini,Anna Lok,Douglas D. Richman,William F. Carman,Jules L. Dienstag,Raymond F. Schinazi.??Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region(J)Hepatology . 2001 (3)
10Hadziyannis SJ,Tassopoulos NC,Heathcote EJ,et al.Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. New England Journal of Medicine, The . 2005
